Nuveen Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.64M | Hold |
301,571
| – | – | ﹤0.01% | 2464 |
|
|
2024
Q3 | $2.51M | Sell |
301,571
-81,108
| -21% | -$674K | ﹤0.01% | 2309 |
|
|
2024
Q2 | $2.74M | Buy |
382,679
+185,000
| +94% | +$1.32M | ﹤0.01% | 2225 |
|
|
2024
Q1 | $1.71M | Sell |
197,679
-53,145
| -21% | -$461K | ﹤0.01% | 2466 |
|
|
2023
Q4 | $1.64M | Buy |
250,824
+14,930
| +6% | +$97.8K | ﹤0.01% | 2504 |
|
|
2023
Q3 | $2.36M | Sell |
235,894
-69,622
| -23% | -$696K | ﹤0.01% | 2226 |
|
|
2023
Q2 | $3.8M | Buy |
305,516
+14,656
| +5% | +$182K | ﹤0.01% | 2047 |
|
|
2023
Q1 | $4.08M | Sell |
290,860
-60,303
| -17% | -$845K | ﹤0.01% | 2004 |
|
|
2022
Q4 | $5.03M | Buy |
351,163
+2,067
| +0.6% | +$29.6K | ﹤0.01% | 1900 |
|
|
2022
Q3 | $8.91M | Sell |
349,096
-16,496
| -5% | -$421K | ﹤0.01% | 1550 |
|
|
2022
Q2 | $10.4M | Buy |
365,592
+4,365
| +1% | +$124K | ﹤0.01% | 1479 |
|
|
2022
Q1 | $13.9M | Buy |
361,227
+14,651
| +4% | +$564K | ﹤0.01% | 1428 |
|
|
2021
Q4 | $13.6M | Sell |
346,576
-143,958
| -29% | -$5.67M | ﹤0.01% | 1495 |
|
|
2021
Q3 | $24.1M | Buy |
490,534
+103,986
| +27% | +$5.1M | 0.01% | 1145 |
|
|
2021
Q2 | $16.1M | Buy |
386,548
+5,860
| +2% | +$245K | ﹤0.01% | 1537 |
|
|
2021
Q1 | $13.6M | Buy |
380,688
+280,688
| +281% | +$10M | ﹤0.01% | 1604 |
|
|
2020
Q4 | $2.81M | Buy |
+100,000
| New | +$2.81M | ﹤0.01% | 2335 |
|